Klow Blend 80mg (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg)

Klow Blend 80mg — Overview

The Klow Blend brings four distinct bioactive compounds together in one vial: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, and KPV 10mg. It’s designed for researchers looking to study how tissue repair, inflammation modulation, and extracellular matrix remodelling intersect within a single experimental setup. By using this formulation, qualified investigators can avoid the logistical hassle of sourcing, reconstituting, and managing four separate vials independently. This product is for research purposes only and is not intended for human administration.

Each of these four components brings its own established research profile to the table. Together, they offer a broad-spectrum approach for researchers looking to study biological repair and inflammatory regulation pathways at the same time.

Component Breakdown

GHK-Cu 50mg

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide–copper complex that has been studied extensively for its effects on wound healing, collagen synthesis, and antioxidant activity. It appears to trigger various tissue repair genes by modulating TGF-β signalling and the ubiquitin–proteasome system. In research models, the concentrations used have shown pro-regenerative effects across skin, liver, lung, and bone tissue, making it one of the more versatile repair-related peptides available. For research teams looking to study it on its own, it is also available as GHK-Cu 50mg.

BPC-157 10mg

BPC-157, or Body Protection Compound 157, is a pentadecapeptide sourced from a gastroprotective protein found in gastric juice. It possesses a wide preclinical profile, showing significant effects on angiogenesis, nitric oxide signalling, gut mucosal healing, and even neurological protection. Researchers have seen it speed up recovery across various tissue injuries in rodent models, from muscle tears and tendon lacerations to bone defects. This versatility is why it is so frequently cited in musculoskeletal and gastrointestinal repair studies. For investigators conducting single-compound work, the standalone BPC-157 5mg vial is also available.

TB-500 10mg

TB-500 (Thymosin Beta-4) is a synthetic version of a natural actin-sequestering protein found throughout most tissues. Its main researched mechanism works by upregulating actin polymerisation and driving cell migration, which is why it is so central to studies on wound healing and tissue regeneration. Beyond that, it has shown anti-inflammatory properties and some interesting effects in models of cardiac and neurological injury. Researchers can find Thymosin Beta-4 (TB-500) 5mg for isolated studies.

KPV 10mg

KPV (Lys-Pro-Val) is a tripeptide pulled from the C-terminus of alpha-melanocyte stimulating hormone (α-MSH). While it’s derived from α-MSH, KPV doesn’t actually trigger melanocyte-stimulating activity. Instead, it keeps those strong anti-inflammatory signalling properties, mostly working through interactions with melanocortin receptors—specifically MC1R—to block NF-κB pathway activation. Researchers have looked into its effects on intestinal inflammation and various skin inflammatory conditions. If you’re running single-compound protocols, the KPV 5mg standalone vial is available. This product is for research purposes only and is not intended for human administration; it should only be handled by qualified investigators.

Research Rationale for Combination Studies

Choosing a blend like Klow over individual compounds is a practical move for exploratory research, especially when you’re focused on the net effect of stimulating multiple repair pathways at once. If your research asks how concurrent modulation of actin dynamics, angiogenesis, copper-dependent gene activation, and melanocortin receptor signalling affects an in vitro wound-healing model, this blend lets you tackle that question efficiently. It cuts out the extra complexity of reconstituting and dosing four separate compounds, keeping the workflow straightforward for qualified investigators. This product is for research purposes only and is not intended for human administration.

Once a biological effect of interest is identified in the blend, researchers usually move to deconvolution. This means testing each component separately to pin the effect to a specific mechanism. It’s why the Klow Blend is most useful for early-stage exploratory or screening work.

Format & Quality

This vial holds 80mg total (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg) supplied as a lyophilised powder blend. We’ve independently verified the purity and identity of every batch, just as we do for everything in this catalogue. Researchers should request the COA for their specific lot and document it in their experimental records.

Intended Use

We supply Klow Blend 80mg for research purposes only. It’s intended exclusively for in vitro, ex vivo, or preclinical laboratory use by qualified research professionals. It is not intended for human administration or diagnostic use.

References

• Pickart L, Vasquez-Soltero JM, Margolina A. “The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging.” Rejuvenation Res. 2012;15(4):351–360.
• Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.” Curr Pharm Des. 2011;17(16):1612–1632.
• Goldstein AL, Hannappel E, Kleinman HK. “Thymosin β4: actin-sequestering protein moonlights to repair injured tissues.” Trends Mol Med. 2005;11(9):421–429.
• Catania A, et al. “The neuropeptide alpha-MSH in host defense.” Ann N Y Acad Sci. 2000;917:227–233.